LFMD · LifeMD, Inc.

Grant of restricted stock units which vest 25,000 on June 1, 2027, 25,000 on June 1, 2028 and the remainder on June 1, 2029.

Grant of restricted stock units which vest 112,500 on March 16, 2027, 112,500 on March 16, 2028 and the remainder on March 16, 2029.

The grant of restricted stock units vest 50,000 on grant date, an additional 50,000 restricted stock units vest on grant date, which are subject to clawback in their entirety should the Owner not be employed by the Issuer through March 30, 2027 for any reason, 50,000 on March 30, 2027 and the remainder on March 30, 2028.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.585 to $3.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth.

The grant of restricted shares vests on June 1, 2026.

The grant of restricted shares vests on June 1, 2026.

The grant of restricted shares vests on June 1, 2026.

The grant of restricted shares vests on June 1, 2026.

Restricted stock units that vest on June 1, 2026.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.87 and $5.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Represents grant of performance stock which vested on August 22, 2025

Includes 10,000 restricted stock units that vest on January 1, 2026, 20,000 restricted stock units that vest on January 1, 2027 and 20,000 restricted stock units that vest on January 1, 2028.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.11 and $13.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.80 and $10.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 and $14.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.57 and $13.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.32 and $12.4900, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.9750 and $12.9200, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.5000 to $7.5050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.500 and $7.620, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth above.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.500 and $8.150, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth.

Represents grant of performance stock which vested on March 31, 2025.

The restricted shares vested in full on March 31, 2025.

Represents grant of performance stock which vested on March 31, 2025.

The restricted stock units vest in full on January 1, 2027.

Represents grant of performance stock which vested on March 31, 2025.

Represents grant of performance stock which vested on March 31, 2025.

Represents grant of performance stock which vested on March 31, 2025.

Represents grant of performance stock which vested on March 31, 2025.

This transaction involved the reporting person's gift of 13,997 shares of LFMD common stock to Child 1.

This transaction involved the reporting person's gift of 13,997 shares of LFMD common stock to Child 2.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the ranges set forth.

Represents grant of performance stock which vested on March 7, 2025.

Represents grant of performance stock which vested on March 7, 2025.

Represents grant of performance stock which vested on March 7, 2025.

Represents grant of performance stock which vested on March 7, 2025.

Represents grant of performance stock which vested on March 7, 2025.

Represents grant of performance stock which vested on March 7, 2025.